EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Am80, a retinoic acid receptor agonist, activates the cardiomyocyte cell cycle and enhances engraftment in the heart

Manabu Kasamoto, Shunsuke Funakoshi, Takeshi Hatani, Chikako Okubo, Yohei Nishi, Yuta Tsujisaka, Misato Nishikawa, Megumi Narita, Akira Ohta, Takeshi Kimura, Yoshinori Yoshida

Stem Cell Reports · 2023

DOI: 10.1016/j.stemcr.2023.06.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cell Reports, 2023. Verfasst von Manabu Kasamoto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for iPS Cell Research and Application, Kyoto University, Kyoto, Japan; Department of Cardiovascular Medicine, Kyoto University Hospital, Kyoto…. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Takeda Pharmaceutical Company, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science London.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacInduced Pluripotent Stem CellsAnimalsMiceHumansReceptors, Retinoic AcidCell CycleCell DifferentiationBenzoatesTetrahydronaphthalenes

Stichwörter der Autor:innen

Cardiac cell transplantationCell cycleFUCCIcardiomyocyte differentiationhigh throughput screeninghuman induced pluripotent stem cellsretinoic acid

Substanzen

Receptors, Retinoic AcidtamibaroteneBenzoatesTetrahydronaphthalenes

Autor:innen und Institutionen

  • Centre for iPS Cell Research and Application, Kyoto University, Kyoto, Japan; Department of Cardiovascular Medicine, Kyoto University Hospital, Kyoto, Japan.
  • Centre for iPS Cell Research and Application, Kyoto University, Kyoto, Japan; Takeda-CiRA Joint program (T-CiRA), Fujisawa, Japan. Electronic address: s.funakoshi@cira.kyoto-u.ac.jp.
  • Centre for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
  • Department of Cardiovascular Medicine, Kyoto University Hospital, Kyoto, Japan.
  • Centre for iPS Cell Research and Application, Kyoto University, Kyoto, Japan; Takeda-CiRA Joint program (T-CiRA), Fujisawa, Japan. Electronic address: yoshinor@cira.kyoto-u.ac.jp.

Förderung

  • Takeda Pharmaceutical Company
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science London
  • Fondation Leducq
  • Japan Society for the Promotion of Science

Zitieren

APA

Kasamoto, M., Funakoshi, S., Hatani, T., Okubo, C., Nishi, Y., Tsujisaka, Y., Nishikawa, M., Narita, M., Ohta, A., Kimura, T., & Yoshida, Y. (2023). Am80, a retinoic acid receptor agonist, activates the cardiomyocyte cell cycle and enhances engraftment in the heart. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2023.06.006

Vancouver

Kasamoto M, Funakoshi S, Hatani T, Okubo C, Nishi Y, Tsujisaka Y, et al. Am80, a retinoic acid receptor agonist, activates the cardiomyocyte cell cycle and enhances engraftment in the heart. Stem Cell Reports. 2023. doi:10.1016/j.stemcr.2023.06.006

BibTeX
@article{Kasamoto2023,
  author = {Kasamoto, Manabu and Funakoshi, Shunsuke and Hatani, Takeshi and Okubo, Chikako and Nishi, Yohei and Tsujisaka, Yuta and Nishikawa, Misato and Narita, Megumi and Ohta, Akira and Kimura, Takeshi and Yoshida, Yoshinori},
  title = {Am80, a retinoic acid receptor agonist, activates the cardiomyocyte cell cycle and enhances engraftment in the heart},
  journal = {Stem Cell Reports},
  year = {2023},
  doi = {10.1016/j.stemcr.2023.06.006}
}
Kostenlos starten →